NCT07083908

Brief Summary

Currently, high resolution anorectal manometry (HDARM) is used as gold standard to measure anal sphincter pressures in women who have sustained a third or fourth degree perineal tears (obstetric anal sphincter injuries). This test is performed to help advise patients on future pregnancies or deliveries. However, HDRM catheters are very expensive and they also need to be performed in a dedicated procedure room. THD® Anopress in comparison is a lightweight, portable device which has a comparatively shorter investigation time and is more cost- effective. However, although THD® Anopress is currently used in the colorectal population, there is currently no validated research that compares the measurements obtained by HDARM with that of THD® Anopress with women with a history of obstetric anal sphincter injuries. The primary aim of this study is to compare pressure measurements from HDARM to that of THD® Anopress in women with obstetric anal sphincter injuries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 24, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2025

Completed
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

February 26, 2025

Last Update Submit

April 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Main voluntary squeeze increment

    Difference between maximum voluntary squeeze pressure and maximum resting pressure (mmHg)

    Day 1

Secondary Outcomes (7)

  • Anal resting pressure (mmHg)

    Day 1

  • Main voluntary squeeze increment

    Day 1

  • Endurance squeeze pressure

    Day 1

  • Straining pressure

    Day 1

  • Total duration of procedure

    Day 1

  • +2 more secondary outcomes

Study Arms (2)

THD® Anopress (Sensyprobe) first

OTHER
Device: THD® Anopress (Sensyprobe) first

High Resolution Anorectal Manometry first

OTHER
Device: High Resolution Anorectal Manometry first

Interventions

Anorectal manometry with THD® Anopress (Sensyprobe) first then with High Resolution Anorectal Manometry (Laborie)

THD® Anopress (Sensyprobe) first

Anorectal manometry with High Resolution Anorectal Manometry (Laborie) first followed by THD® Anopress (Sensyprobe)

High Resolution Anorectal Manometry first

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients with a history of obstetric anal sphincter injury and are:
  • a) At least 6 weeks postpartum
  • Either able to speak, read and write in English, or has a professional interpreter present at the time of appointment.
  • Capable of understanding and signing the informed consent form after full discussion of the investigations and its risks and benefits.
  • Able and willing to complete the St Mark's Score, ICIQ-UI SF and other trial related questionnaires, comply with scheduled clinic visits and manometry studies.

You may not qualify if:

  • Existing anal pain precluding anorectal examination
  • Neurological conditions such as stroke, multiple sclerosis, spinal cord injury or Parkinson's disease
  • Age \<18 years old
  • Currently pregnant -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kings College Hospital

London, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2025

First Posted

July 24, 2025

Study Start

March 1, 2025

Primary Completion

November 11, 2025

Study Completion

November 11, 2025

Last Updated

April 16, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations